Home›Companies›Biotech & Pharma›Evecxia

Evecxia, Inc.

Updated Oct 29, 2026·Latest SEC filing Sep 29, 2025·Suggest an edit

About Evecxia

Evecxia is a private company based in Research Triangle Park, North Carolina. It has reported $23,136,141 raised in five offerings on Form D since April 2018. Its chief executive is Jacob Jacobsen.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 15, 2025Sep 29, 2025$4,613,213of $8.0M target97$47,559EquityRule 506(b)Form D ↗
Aug 22, 2023Sep 6, 2023$2,438,082of $8.0M target76$32,080Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Aug 6, 2021Aug 20, 2021$8,620,691of $35.0M target75$114KEquityRule 506(b)Form D ↗
Sep 12, 2019Sep 17, 2019amended Sep 11, 2020$7,414,155of $8.5M target91$81,474EquityRule 506(b)Form D/A ↗1 earlier filing
Apr 5, 2018Apr 13, 2018$50,000of $150K target2$25,000Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Total, five offerings$23,136,141

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Evecxia's Form D filed Sep 29, 2025.

JJ
Jacob Jacobsen
Chief Executive Officer and director
EE
AS
Allan Shaw
Director
JK
John Kaiser
Director

Earlier filings also listed Thomas Aasen (director, last listed Aug 2021), David Zaccardelli (director, last listed Aug 2021), Roger Jeffs (director, last listed Sep 2020) and Marc Caron (executive officer and director, last listed Sep 2020).

Sources

  1. SECEvecxia, Inc. Form D, filed Sep 17, 2019
  2. SECEvecxia, Inc. filing history